The trademark application Jublia was filed by Kaken Pharmaceutical Co., Ltd., a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on September 2, 2025, and still open for oppositions.
The application was filed in English (French was selected as the second language).